This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Sunshine Lake Pharma Co., Ltd., North & South Brother Pharmacy Investment Company Limited. Active years: 2019-2022.
Company Filing History:

Years Active: 2019-2022
Title: Innovations by Junjun Yin in Influenza Virus Research
Introduction
Junjun Yin is a notable inventor based in Dongguan, China, recognized for his contributions to the field of pharmaceutical sciences. He holds 8 patents that focus primarily on inhibitors of influenza virus replication. His work has significant implications for the treatment of influenza, showcasing his commitment to advancing medical research.
Latest Patents
Among his latest patents, Junjun Yin has developed a novel class of compounds that serve as inhibitors of influenza virus replication. The first patent details the preparation methods and pharmaceutical compositions containing these compounds, emphasizing their potential uses in treating influenza. The second patent discloses a specific compound, represented by a formula, as an influenza virus replication inhibitor, along with its preparation method and applications in pharmaceutical compositions for influenza treatment.
Career Highlights
Throughout his career, Junjun Yin has worked with prominent companies in the pharmaceutical industry, including Sunshine Lake Pharma Co., Ltd. and North & South Brother Pharmacy Investment Company Limited. His experience in these organizations has allowed him to contribute significantly to the development of antiviral therapies.
Collaborations
Junjun has collaborated with esteemed colleagues, including Qingyun Ren and Changhua Tang, who have supported his research endeavors. Their combined expertise has furthered the understanding and development of antiviral compounds.
Conclusion
Junjun Yin's innovative work in the field of influenza virus research highlights his dedication to improving public health through scientific advancements. His patents and collaborations reflect a strong commitment to combating viral infections and enhancing treatment options.